This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Onyx Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Eric Lowe: Innovator in Cancer Treatment
Introduction
Eric Lowe is a notable inventor based in Moraga Town, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on the use of peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors.
Latest Patents
Eric Lowe holds 1 patent for his invention titled "Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers." This patent outlines methods for treating cancer in patients by utilizing a peptide epoxyketone proteasome inhibitor alongside a PIM kinase inhibitor.
Career Highlights
Throughout his career, Eric has worked with prominent companies in the pharmaceutical industry, including Onyx Pharmaceuticals, Inc. and Onyx Therapeutics, Inc. His experience in these organizations has allowed him to contribute to groundbreaking advancements in cancer therapies.
Collaborations
Eric has collaborated with talented individuals in his field, including Shirin Kapur and Alana Lerner. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer treatments.
Conclusion
Eric Lowe's contributions to cancer treatment through his patented methods demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile